BDNF
Full Name	Brain-Derived Neurotrophic Factor
Chromosome	11p14.1
Gene Type	Protein-coding gene
NCBI Gene ID	627
OMIM	113505
Ensembl ID	ENSG00000176697
UniProt	P23560
Protein Family	Neurotrophin family
Receptors	TrkB (NTRK2), p75NTR (TNFRSF1B)
Major Pathways	PI3K/Akt, MAPK/ERK, PLCγ
Primary Disease Links	AD, PD, HD, Depression, Rett Syndrome
Associated Diseases	ADHD, ALS, ALZHEIMER, ALZHEIMER'S DISEASE, AUTISM
SciDEX Hypotheses	Hippocampal CA3-CA1 circuit rescue via n...
KG Connections	2350 edges

BDNF Gene

Introduction

Brain-Derived Neurotrophic Factor (BDNF) is the most widely expressed neurotrophin in the mammalian brain and plays essential roles in neuronal development, survival, synaptic plasticity, and cognitive function. Discovered in the 1980s as a member of the neurotrophin family, BDNF has become one of the most studied neurotrophic factors in the context of neurodegenerative diseases, psychiatric disorders, and neural repair. ^{1Brain-derived neurotrophic factor2004 · Growth Factors · PMID 15518235Open reference}

BDNF is unique among neurotrophins in that its expression is highly activity-dependent, with neuronal activity, learning, exercise, and environmental enrichment all increasing BDNF transcription. This activity-dependent regulation makes BDNF a critical mediator of experience-dependent neural plasticity.

Molecular Biology

Gene Structure

The BDNF gene is located on chromosome 11p14.1 and consists of 11 exons and 9 functional promoters, making it one of the most complexly regulated neurotrophin genes. This complex promoter architecture allows for tissue-specific, developmental stage-specific, and activity-dependent regulation.

Key exons:

• Exon 1: Brain-specific promoter

• Exon 2: Activity-dependent promoter (contains CREB binding sites)

• Exon 3-9: Additional regulatory elements

Protein Processing

BDNF is synthesized as a precursor protein (pro-BDNF, ~32 kDa) that undergoes proteolytic processing to generate the mature BDNF (~14 kDa):^{2Activation of MAP kinase by BDNF1994 · Cell · PMID 7954754Open reference}

1. Pre-pro-BDNF: Initial translation product with signal peptide

2. Pro-BDNF: Secreted form that can signal through p75NTR to induce apoptosis

3. Mature BDNF: Final processed form that binds TrkB with high affinity

The balance between pro-BDNF and mature BDNF is critical for neural development and plasticity.

Receptor Signaling

TrkB Receptor

BDNF signals primarily through the TrkB (Tropomyosin receptor kinase B, encoded by NTRK2) receptor:^{3Trk receptors: roles in neuronal signal transduction2003 · Annu Rev Neurosci · PMID 11747827Open reference}

Receptor structure:

• Extracellular domain: Leucine-rich repeat domains for ligand binding

• Transmembrane domain: Single pass receptor

• Cytoplasmic domain: Tyrosine kinase domain

TrkB isoforms:

• Full-length TrkB (TrkB-FL): Contains cytoplasmic kinase domain

• TrkB-T1: Truncated isoform acting as dominant-negative

Signaling Pathways

BDNF binding to TrkB activates multiple downstream cascades:^{4TrkB signaling in dendrites and synaptic plasticity2012 · J Neurochem · PMID 22339773Open reference}

PI3K/Akt Pathway

• recruitment of PI3K to phosphorylated TrkB phosphotyrosines

• Akt phosphorylation promotes neuronal survival

• Key targets: BAD phosphorylation (inhibition), mTOR activation

MAPK/ERK Pathway

• Ras activation recruited via Shc adaptor

• MEK phosphorylation activates ERK1/2

• ERK promotes:

  • Gene transcription (via CREB)

  • Synaptic plasticity

  • Neuronal differentiation

PLCγ Pathway

• PLCγ recruitment and activation

• IP3 and DAG production

• Calcium release from internal stores

• PKC activation

• Synaptic plasticity mechanisms

p75NTR Signaling

The p75 neurotrophin receptor can also bind BDNF, with context-dependent effects:

Pro-BDNF/p75NTR signaling:

• Induces apoptosis during development

• Activates JNK pathway

• Mediates pruneUnused synapses

Mature BDNF/p75NTR signaling:

• Can enhance survival in some contexts

• May function as co-receptor with TrkB

• Regulation of synaptic plasticity

Expression and Regulation

Brain Region Distribution

BDNF is highly expressed in:^{5BDNF: a key factor in synaptic plasticity and memory2018 · J Neural Transm · PMID 28925391Open reference}

• Hippocampus: CA1-CA3 pyramidal neurons, dentate gyrus granule cells

• Cortex: Layers II-III, V pyramidal neurons

• Basal forebrain: Cholinergic neurons

• Substantia nigra: Dopaminergic neurons

• Cerebellum: Purkinje cells

• Amygdala: Principal neurons

Activity-Dependent Regulation

BDNF expression is highly regulated by neuronal activity:

Upregulating factors:

• Synaptic activity: Calcium influx through NMDA receptors

• Seizure activity: Kainate-induced seizures dramatically increase BDNF

• Learning: Hippocampal-dependent learning tasks

• Exercise: Voluntary and forced exercise

• Environmental enrichment: Complex housing environments

• Antidepressants: SSRIs, ECT, ketamine

Downregulating factors:

• Stress: Glucocorticoids reduce BDNF

• Aging: BDNF expression declines with age

• Neurodegeneration: Reduced BDNF in AD, PD, HD brains

Roles in the Nervous System

Development

During neural development, BDNF mediates:^{6BDNF and activity-dependent neuronal survival1995 · Neurochem Res · PMID 7848693Open reference}

1. Neuronal survival: Supports post-mitotic neuron survival

2. Differentiation: Promotes neuronal phenotype

3. Process outgrowth: Axon and dendrite development

4. Synaptogenesis: Formation of functional synapses

5. Dendritic arborization: Complex dendritic branching

Synaptic Plasticity

BDNF is a critical mediator of activity-dependent synaptic changes:^{7BDNF and synaptic plasticity in the adult brain2002 · Learn Mem · PMID 12152066Open reference}

Long-term potentiation (LTP):

• BDNF enhances LTP in hippocampus

• TrkB activation required for LTP maintenance

• BDNF application rescues LTP deficits

Long-term depression (LTD):

• Pro-BDNF/p75NTR signaling mediates LTD

• Synaptic prune during development

Homeostatic plasticity:

• Scaling of synaptic strength

• Regulation of excitation/inhibition balance

Memory and Cognition

BDNF is essential for learning and memory:^{5BDNF: a key factor in synaptic plasticity and memory2018 · J Neural Transm · PMID 28925391Open reference}

• Hippocampal-dependent learning tasks impaired in BDNF knockout mice

• BDNF Val66Met polymorphism affects:

  • Hippocampal volume

  • Memory performance

  • Treatment response in depression

Disease Associations

Alzheimer’s Disease

BDNF alterations in AD:^{8BDNF: a key therapeutic target for Alzheimer's disease2013 · Nat Rev Neurol · PMID 23296339Open reference}

Expression changes:

• BDNF protein reduced in AD hippocampus

• BDNF mRNA decreased in AD brain

• Correlation between BDNF and cognitive function

Pathological mechanisms:

• Amyloid-beta reduces BDNF expression

• Tau pathology affects BDNF signaling

• Synaptic loss correlates with BDNF reduction

Therapeutic strategies:

• AAV-BDNF gene therapy

• Recombinant BDNF protein

• TrkB agonists (7,8-DHF, BDNF mimetics)

• Exercise and cognitive training

Preclinical results:

• AAV-BDNF improves cognition in AD models^{9AAV-mediated BDNF expression improves cognitive deficits in Alzheimer's disease models2015 · Mol Neurobiol · PMID 25557367Open reference}

• Reduces amyloid pathology

• Enhances synaptic markers

Parkinson’s Disease

BDNF supports dopaminergic neurons:^{2Activation of MAP kinase by BDNF1994 · Cell · PMID 7954754Open reference}0

Dopaminergic protection:

• Supports substantia nigra neuron survival

• Protects against MPTP toxicity

• Maintains tyrosine hydroxylase expression

Therapeutic development:

• AAV-BDNF to striatum (clinical trials)

• AAV-BDNF with AAV-GDNF combinations

• Stem cell-derived BDNF

Huntington’s Disease

BDNF is crucial for striatal neuron function:^{2Activation of MAP kinase by BDNF1994 · Cell · PMID 7954754Open reference}1

Dysregulation in HD:

• BDNF expression reduced in HD brain

• Impaired BDNF transport in HD

• Mutant huntingtin affects BDNF transcription

Therapeutic potential:

• Restore BDNF levels

• AAV-BDNF gene therapy

• TrkB agonist therapy

Major Depressive Disorder

BDNF is a key mediator of antidepressant efficacy:^{2Activation of MAP kinase by BDNF1994 · Cell · PMID 7954754Open reference}2

Clinical findings:

• Reduced serum BDNF in depression

• Antidepressants increase BDNF

• BDNF Val66Met affects treatment response

Mechanisms:

• SSRIs increase BDNF expression

• ECT dramatically elevates BDNF

• Ketamine rapid antidepressant effects involve BDNF

Other Conditions

Rett Syndrome:

• Reduced BDNF in mouse models

• BDNF therapy rescues phenotypes

Epilepsy:

• BDNF contributes to epileptogenesis

• Aberrant mossy fiber sprouting

Therapeutic Targeting

Delivery Strategies

Approach	Advantages	Limitations	Status
Recombinant BDNF	Well-characterized	BBB penetration	Preclinical
AAV-BDNF	Long-term expression	Immune response	Clinical trials
TrkB agonists	Oral delivery	Specificity	Preclinical
Exercise	Natural, safe	Variable	Proven
Antidepressants	FDA-approved	Indirect	Approved

TrkB Agonists

Small molecule TrkB agonists being developed:

• 7,8-Dihydroxyflavone (7,8-DHF): First-generation agonist

• Nor-BDNF: BDNF peptiderivative

• TrkB-selective compounds: Newer generations

Gene Therapy

AAV-mediated BDNF delivery:^{2Activation of MAP kinase by BDNF1994 · Cell · PMID 7954754Open reference}3

• AAV2/9 serotypes for CNS

• Promoters for neuron-specific expression

• Regulated expression systems

• Safety considerations

Animal Models

BDNF Knockout Mice

Complete BDNF knockout is embryonic lethal, demonstrating the essential role during development. Conditional knockout models have provided crucial insights:

** forebrain-specific knockout:**

• Impaired LTP

• Deficits in hippocampal-dependent memory

• Reduced anxiety-like behavior

Neuron-specific knockout:

• Loss of cortical and hippocampal neurons

• Impaired synaptic plasticity

• Behavioral abnormalities

BDNF Overexpression Models

Transgenic overexpression:

• Enhanced learning and memory

• Increased synaptic density

• Resistance to metabolic stress

Viral-mediated overexpression:

• AAV-BDNF in various brain regions

• Rescue of cognitive deficits in AD models

• Neuroprotection in PD models

Pharmacological Modulation

TrkB Agonists

Compound	Mechanism	Stage	Notes
7,8-DHF	TrkB agonist	Preclinical	First-generation
Nor-BDNF	BDNF derivative	Research	More stable
R13	TrkB-selective	Preclinical	Oral bioavailability
ANA-12	TrkB antagonist	Research	Used to study BDNF role

Anxiolytic and Antidepressant Effects

BDNF mediates the effects of:

• SSRIs: Increase BDNF expression

• ** ketamine**: Rapid antidepressant via TrkB

• Exercise: Natural BDNF enhancer

• ECS: Potent BDNF inducer

Genetic Variants

BDNF Val66Met Polymorphism

The functional Val66Met polymorphism (rs6265) affects:

• Activity-dependent secretion

• Hippocampal function

• Memory performance

• Treatment response in depression

• Risk for various neuropsychiatric conditions

Other Common Variants

• BDNF promoter polymorphisms

• 5’ UTR variants

• 3’ UTR regulatory variants

• Copy number variants

Cross-Links

• Brain-Derived Neurotrophic Factor — protein information

• TrkB Signaling Pathway

• Neurotrophin Signaling in Neurodegeneration

• Alzheimer’s Disease

• Parkinson’s Disease

• Huntington’s Disease

• Hippocampus

• Dopaminergic Neurons

• Synaptic Plasticity

External Links

• NCBI Gene: BDNF

• UniProt: BDNF

• Ensembl: BDNF

• OMIM: BDNF

• Allen Human Brain Atlas: BDNF

• ClinicalTrials.gov: BDNF

---